AI helping remove Chinese goods made with Uyghur forced labor from corporate supply chains
Altana Technologies developed an AI-informed supply chain mapping system used by Customs and Border Protection and a number of firms to root out Uyghur forced labor from supply chains.
Corporate diversity policies may face scrutiny after Supreme Court's affirmative action ruling
The Supreme Court's ruling rejecting the use of affirmative action and consideration of race as a factor in college admissions could prompt challenges to companies' diversity programs.
LARRY KUDLOW: Biden's op-ed on the economy is chock full of Pinocchios
FOX Business host Larry Kudlow dissects the 'untruths' in President Biden's Wall Street Journal op-ed in his opening monologue on 'Kudlow.'
Merck sues Biden HHS for drug price-fixing 'sham' it says would cripple pharmaceutical industry
Pharmaceutical company Merck has filed a lawsuit against the Biden administration for a new drug pricing program it says is an unconstitutional "sham."
India set to release newly developed cervical cancer vaccine soon
The Serum Institute of India (SII) has recently announced that they have successfully developed the world's first cervical cancer vaccine, which will soon hit shelves soon.
Merck’s COVID-19 pill heavily used so far despite concerns
A new COVID-19 pill from Merck & Co. and Ridgeback Biotherapeutics LP has been more widely used than expected since rolling out late last year, though regulators and many doctors consider it a last resort.
Western drugmakers are still providing medicines to Russia
Western health care companies continue supplying medicine, vaccines and medical equipment to Russia.
FDA authorizes second COVID-19 antiviral pill, Merck's molnupiravir
The Food and Drug Administration on Thursday authorized the use of Merck's molnupiravir pill for treating COVID-19, the second such emergency use authorization in two days.
Merck COVID pill effective, experts will review safety: FDA
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems in pregnant women.
Merck COVID-19 pill sparks calls for access for lower income countries
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.